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Objectives This study sought to determine whether epicardial fat volume predicts coronary events in the general population.
Background Epicardial adipose tissue (EAT) is suggested to promote plaque development in the coronary artery tree.
Methods We quantified EAT volume in participants from the prospective population-based Heinz Nixdorf Recall cohort
study free of cardiovascular disease. Incident coronary events were assessed during a follow-up period of 8.0 
1.5 years. Multivariable association of EAT with cardiovascular risk factors, coronary artery calcification (CAC),
and coronary events was assessed using regression analysis.
Results From the overall 4,093 participants (age 59.4 years, 47% male), 130 subjects developed a fatal or nonfatal cor-
onary event. Incidence of coronary events increased by quartile of EAT (0.9% vs. 4.7% for 1st and 4th quartile,
respectively, p  0.001). Doubling of EAT was associated with a 1.5-fold risk of coronary events when adjusting
for cardiovascular risk factors (hazard ratio [HR] [95% confidence interval (CI)]: 1.54 [1.09 to 2.19]), which re-
mained unaltered after further adjustment for CAC score (HR [95% CI]: 1.50 [1.07 to 2.11]). For discrimination
of subjects with events from those without, we observed a trend for improvement of Harrell’s C and explained
variance by EAT over traditional cardiovascular risk factors, which, however, did not reach statistical significance
(0.720 to 0.730 for risk factors alone and with EAT added, respectively, p  0.10, R2  2.73% to R2  2.92%,
time-dependent integrated discrimination improvement  0.196%).
Conclusions Epicardial fat is associated with fatal and nonfatal coronary events in the general population independent of tra-
ditional cardiovascular risk factors and complements information from cardiac computed tomography above the
CAC score. (J Am Coll Cardiol 2013;61:1388–95) © 2013 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.11.062Epicardial adipose tissue (EAT) is a visceral adipose
tissue surrounding the heart and the coronary arteries.
Because of its endocrine and paracrine activity, secreting
pro-inflammatory and anti-inflammatory cytokines and
chemokines, it has been suggested to influence coronary
atherosclerosis development (1–5). EAT is associated
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2012, accepted November 8, 2012.with cardiovascular risk factors (6,7), coronary athero-
sclerosis (8 –10), and prevalent coronary artery disease
(11–13). In addition, a case-control study, drawn from
the MESA (Multi-Ethnic Study of Atherosclerosis),
suggested a role of increased EAT volume for coronary
event manifestation (14). However, to date, large-
population– based longitudinal data on the prognostic
value of EAT fat for prediction of hard coronary events
are lacking.
See page 1396
Cardiac computed tomography (CT) imaging of the
heart is the gold standard for EAT quantification with
non-contrast enhanced cardiac CT enabling risk assessment
through coronary artery calcification (CAC) quantification
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April 2, 2013:1388–95 Epicardial Fat and Coronary Events(15–17). However, because EAT is associated with coronary
atherosclerosis, implications of EAT on risk assessment
above CAC remains unknown.
Therefore, the aim of the present study was to determine
the association of epicardial fat volume with incident fatal and
nonfatal coronary events in the population-based cohort of the
Heinz Nixdorf Recall study. Furthermore, we aimed to investigate
whether or not a potential prognostic value of EAT is indepen-
dent of CAC.
Methods
Study cohort. The Heinz Nixdorf Recall study is a
population-based prospective cohort study, designed to
assess the predictive value of novel markers for risk strati-
fication in addition to traditional cardiovascular risk factors.
The participants (age 45 to 75 years) were randomly selected
from mandatory lists of residence from the 3 adjacent cities
of Bochum, Essen, and Mülheim, and enrolled between
2000 and 2003. Details for recruitment and study design
have been previously published (15,18). Overall response
rate was 56%. For this analysis, we excluded subjects with
known coronary artery disease, history of myocardial infarc-
tion, or history of open heart surgery (including bypass and
valve surgery) at baseline. All participants provided written
informed consent, and the study was approved by the
institutional ethics committee.
Cardiovascular risk factor assessment. Traditional car-
diovascular risk factors were measured at baseline, with
details being previously published (19). Waist circumference
was measured at the leanest circumference between the
costal arch and the iliac crest. Standardized enzymatic
methods were used to determine serum total cholesterol
level, high-density lipoprotein (HDL) cholesterol, and low-
density lipoprotein (LDL) cholesterol. Diabetes was defined
as a history of diabetes, being on medical treatment for
diabetes, or having blood glucose levels as previously pub-
lished (20). Smoking history was classified in current and
former smokers, as well as in patients with no history of
smoking, assessed by computer-assisted interview (21).
Cardiac CT. As part of the study, subjects underwent
cardiac CT for quantification of artery CAC. Electron beam
CT scans were performed utilizing a C-100 or C-150
scanner (GE Imatron, South San Francisco, California)
without the use of contrast media. Imaging was prospec-
tively triggered at 80% of the RR interval, and contiguous
3-mm-thick slices from the right pulmonary artery to the
apex of the heart were obtained at an image acquisition time
of 100 ms. CAC was defined as a focus of at least 4
contiguous pixels with a CT density 130 Hounsfield units
(HU) and quantified using the Agatston method (22).
Epicardial fat volume quantification. Epicardial fat vol-
ume was assessed using a dedicated workstation. The
pericardium was manually traced from the right pulmonary
artery to the diaphragm to determine a region of interest.
Within the region of interest, fat was defined as pixels twithin a window of 195 to
45 HU and a window center of
120 HU. Overall, only pixels
with Hounsfield units equivalent
to fat within the pericardial sac
were counted as epicardial adi-
pose tissue. Reproducibility was
excellent (intraclass correlation
coefficient  0.988, p  0.0001,
for interobserver and intraclass
correlation coefficient  0.996,
p  0.0001, for intraobserver
ariability). Details of EAT
uantification have been previ-
usly described in detail (8). In
ddition to overall epicardial fat
olume, we determined the peri-
oronary fat area of each of the 3
oronary vessels in a subgroup of participants that received
nitial revascularization of a single coronary artery for acute
reatment of the coronary event. Therefore, the area of the
picardial fat around the coronary artery in the middle of the
roximal segment was quantified by manual delineation
fter 3-dimensional reconstruction of an image perpendic-
lar to the coronary vessel.
ollow-up and endpoint definition. Primary endpoints
ere defined as incident coronary events that met pre-
efined study criteria as previously described (18). In brief,
uestionnaires on the current state of health including
uestions about current medications, hospital admissions,
nd outpatient diagnosis of cardiovascular disease were
nnually sent to the participants. In parallel, all death
ertificates were regularly screened. Incident cardiovascular
orbidity and fatal events were validated by review of
ospital records and records of the attending physicians, and
lassified by an external endpoint committee, blinded to the
isk factor status and the CAC score. Myocardial infarction
as defined based on symptoms, electrocardiographic signs,
nd enzymes (levels of creatine kinase, as well as troponin T
r I), and necropsy as: 1) nonfatal acute myocardial infarc-
ion; and 2) coronary death.
tatistical analysis. Continuous variables are reported as
ean  SD or median (interquartile range). Discrete
ariables are given in frequency and percent. Distribution of
ardiovascular risk factors was assessed per quartiles of
AT. Differences between quartiles of EAT were assessed
sing trend test (tests for non-zero Spearman correlation).
inear regression analysis was used to investigate the
ultivariable-adjusted association of EAT with cardiovas-
ular risk factors, including age, sex, waist circumference,
ystolic blood pressure, hypertensive medication, diabetes,
nd smoking. Log2(EAT) was used to adjust for right
kewness of EAT volume, and regression coefficients were
etransformed to demonstrate multiplicative effect sizes on
AT volume related to covariables. Likewise, the associa-
Abbreviations
and Acronyms
CAC  coronary artery
calcification
CHD  coronary heart
disease
CI  confidence interval
CT  computed
tomography
EAT  epicardial adipose
tissue
HDL  high-density
lipoprotein
HR  hazard ratio
LDL  low-density
lipoproteinion of EAT with CAC was assessed using linear regression
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Epicardial Fat and Coronary Events April 2, 2013:1388–95analysis, adjusting for cardiovascular risk factors. Due to the
distributional properties of log(CAC1), we cross-checked
the association of EAT and CAC using tertiles of CAC. In
this model, CAC increases the coefficient of determination
with a negative regression coefficient, which hints towards
CAC being a negative suppressor in the model (23). Partial
correlation further demonstrates this effect. Mean epicardial
fat volume in subjects with and without events was com-
pared using t test, and a smoothed kernel estimate was used
o depict differences in distribution between both groups.
ssociation of EAT with coronary events during follow-up
as assessed using Cox regressions with adjustment sets as
ollows: 1) unadjusted; 2) age and sex adjusted; 3) additional
djustment for traditional risk factors including waist cir-
umference, systolic blood pressure, hypertensive medica-
ion, LDL-cholesterol, HDL-cholesterol, lipid-lowering
edication, diabetes, smoking; and 4) model 3  CAC
score (as log(CAC1) or as tertiles of CAC). Hazard ratios
(HRs) were calculated per each doubling of EAT
(log2(EAT)). Due to the high correlation of waist circum-
ference and body mass index in our cohort (r  0.81, p 
0.0001), ancillary adjustment of body mass index in multi-
variable models was not possible. For sex- and CAC-
specific analyses, unadjusted models were used due to the
limited amount of events in each subgroup.
Pericoronary fat area was normally distributed. A t test
was used to evaluate a potential difference in pericoronary
fat area in vessels with the culprit lesion compared with
those without.
To investigate a predictive value of EAT (log2(EAT)),
Harrell’s C and time-dependent integrated discrimination
improvement (IDI(t)) were used (24). All analyses were
performed using SAS software (version 9.2, SAS Institute,
Baseline Characteristics of the Entire Cohort and Stratified by QuaTable 1 Baseline Characteristics of the Entire Cohort and Stra
Overall
(N  4,093)
1st Quartile
(n  1,023)
Age, yrs 59.4 7.8 56.8 7.5
Men 1,928 (47.1) 218 (21.3)
Waist circumference, cm 93.7 13.13 82.8 10.0
Systolic blood pressure, mm Hg 132.9 20.7 125.3 20.2
Diastolic blood pressure, mm Hg 81.5 10.8 78.0 10.3
Antihypertensive medication 1,309 (32.0) 193 (18.9)
Total cholesterol, mg/dl 231.1 38.8 226.1 37.0
LDL cholesterol, mg/dl 146.8 36.1 138.2 35.4
HDL cholesterol, mg/dl 59.0 17.2 66.9 17.9
Lipid-lowering medication use 366 (8.9) 64 (6.3)
Diabetes 508 (12.4) 40 (3.9)
Smoking
Current 947 (23.1) 225 (22.0)
Former 1,357 (33.2) 269 (26.3)
Never 1,789 (43.7) 529 (51.7)
CAC score 12.6 (0.0–116.0) 1.0 (0–37.9)
Epicardial fat volume, cm3 85.9 (61.4–120.9) 47.6 (38.9–54.6)
Fatal or nonfatal coronary event 130 (3.2) 9 (0.9)Values are mean  SD, n (%), or median (interquartile range).
CAC  coronary artery calcification; HDL  high-density lipoprotein; LDL  low-density lipoprotein.Cary, North Carolina) except comparison of Harrell’s C,
which was evaluated using Stata/IC version 11.2 (StataCorp
LP, College Station, Texas). A p value of 0.05 indicated
statistical significance.
Results
In this analysis, 4,093 subjects (mean age 59.4 years, 47.1%
men) were included with detailed study characteristics
depicted in Table 1. From the initial cohort of 4,814
subjects (response rate 56%), 327 subjects were excluded due
to coronary heart disease at baseline, and 9 of the remaining
individuals had prior valve surgery. A CT scan was not
available for EAT quantification in an additional 313
subjects, and 1 or more covariables were missing in 72 of the
remaining individuals.
Overall, EAT volume showed a wide range with a
median (quartile 1; quartile 3) volume of 85.9 ml (61.4;
120.9; range 12.99 to 390.0 ml). Prevalence of traditional
cardiovascular risk factors increased with quartiles of EAT
(all p  0.05) (Table 1). This trend remained in multivari-
ble analysis, with EAT being significantly associated with
ll investigated risk factors except for systolic blood pressure
nd lipid-lowering medication (Table 2). Similar results
ere observed when stratifying by sex (detailed data not
hown).
In univariate analysis, the median CAC score increased
ith quartiles of EAT (1.0 for the 1st quartile, 58.8 for the
th quartile, p  0.001). However, there was a trend
owards lower EAT in subjects with increased CAC score
fter adjusting for traditional cardiovascular risk factors,
ith a multiplicative effect size below unity (0.99 [95%
onfidence interval (CI): 0.99 to 1.00], p  0.02), yet
of Epicardial Fatby Quartiles of Epicardial Fat
2nd Quartile
(n  1,022)
3rd Quartile
(n  1,024)
4th Quartile
(n  1,024) p Value
59.0 7.4 60.0 7.8 61.7 7.5 0.001
91 (38.3) 559 (54.6) 760 (74.2) 0.001
90.1 9.8 96.8 9.6 105.2 11.4 0.001
30.6 19.7 136.2 20.2 139.5 20.0 0.001
80.8 10.0 82.8 10.8 84.4 11.0 0.001
81 (27.5) 345 (33.7) 490 (47.9) 0.001
33.4 38. 7 232.9 38.7 232.0 40.2 0.002
49.2 36.7 149.9 34.8 150.0 36.3 0.001
60.9 16.1 56.4 16.0 51.7 15.0 0.001
86 (8.4) 111 (10.8) 105 (10.3) 0.001
77 (7.5) 167 (16.3) 224 (21.9) 0.001
14 (21.0) 251 (24.5) 257 (25.1) 0.03
13 (30.6) 355 (34.7) 420 (41.0) 0.001
95 (48.4) 418 (40.8) 347 (33.9) 0.001
.1 (0–62.4) 21.9 (1.0–129.7) 58.8 (7.7–246.3) 0.001
.1 (67.4–79.6) 101.2 (94.0–110.6) 150.5 (133.7–178.3)
22 (2.2) 51 (5.0) 48 (4.7) 0.001rtilestified
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April 2, 2013:1388–95 Epicardial Fat and Coronary Eventsadding only 0.06% to the coefficient of determination.
Similar results were observed when adjusting for tertiles of
CAC instead of log(CAC1) (effect sizes 0.96 [95% CI:
0.93 to 0.99], p  0.01, and 0.96 [95% CI: 0.92 to 0.99],
p  0.01, for the 2nd and 3rd tertiles, respectively). This
uggests that the linkage of EAT with the CAC score in
nivariate analysis is ultimately caused by shared risk factors.
ccordingly, CAC itself was considerably (R2  0.32) related
to cardiovascular risk factors, being a negative suppressor in the
full model, as also indicated by a positive correlation coefficient
of CAC with EAT (r  0.31, p  0.0001), but a negative
orrelation coefficient when traditional risk factors were par-
ialled out (r  0.035, p  0.02). Similar results were
bserved when adjusting for tertiles of CAC instead of log-
CAC1) (effect sizes 0.96 [95% CI: 0.93 to 0.99], p 0.01,
nd 0.96 [95% CI: 0.92 to 0.99], p 0.01, for the 2nd and 3rd
tertiles, respectively).
Multivariable Adjusted Linear Regressions BetweenCardiovascu ar Risk Factors and Epicardial Fat VolumTable 2 Multivari ble Adjusted Linear Regressions BetweenCardiovascular Risk Factors and Epicardial Fat Volume
Epicardial Fat Volume
Multiplicative Effect Size
(95% CI) p Value
Age, 5 yrs 1.05 (1.04–1.06) 0.001
Women 0.87 (0.85–0.90) 0.001
Waist circumference, 5 cm 1.11 (1.10–1.11) 0.001
Systolic blood pressure, 10 mm Hg 1.00 (1.00–1.01) 0.24
Antihypertensive medication use 1.06 (1.04–1.01) 0.001
LDL cholesterol, 10 mg/dl 1.01 (1.00–1.01 ) 0.001
HDL cholesterol, 10 mg/dl 0.99 (0.98–1.00) 0.02
Lipid-lowering medication use 1.03 (0.99–1.07) 0.14
Diabetes 1.07 (1.03–1.11) 0.001
Smoking
Current 1.13 (1.09–1.16) 0.001
Former 1.05 (1.02–1.08) 0.001
Analysis was based on Log2(EAT), and effect sizes were retransformed to demonstrate absolute
differences in epicardial fat volume based on the covariables.
CI  confidence interval; EAT  epicardial adipose tissue; other abbreviations as in Table 1.
Figure 1 Epicardial Fat Volume and Incident Coronary Events
Smoothed kernel estimate for distribution of epicardial fat volume, stratified by incEpicardial fat volume and coronary events. During a
mean follow-up period of 8.0  1.5 years, fatal or nonfatal
coronary events occurred in 130 subjects (3.2%; 39 fatal, 91
nonfatal). Coronary events were more prevalent in men than
in women (91 vs. 39 events, p  0.001). Subjects with
incident coronary events were older and had higher systolic
and diastolic blood pressure, higher waist circumference,
lower HDL-cholesterol levels, and a higher frequency of
antihypertensive medication use, diabetes, and smoking
compared with event-free subjects (all p  0.05). Total
cholesterol levels and frequency of lipid-lowering medica-
tion use were not different between both groups (all p 
0.15). Epicardial fat volume was higher in subjects with
events (121 ml vs. 95 ml, p  0.001) (Fig. 1). Likewise,
frequencies of incident coronary events increased with the
amount of EAT, with subjects in the highest quartile of
EAT having a 5-fold higher risk compared with subjects in
the lowest quartile (Table 1, Fig. 2). In univariate analysis,
doubling of EAT was associated with more than 2-fold
increase of the HR for coronary events (Table 3). After
adjustment for cardiovascular risk factors, EAT volume
remained independently associated with coronary events. In
addition, the HR remained unchanged after further adjust-
ment for CAC score (Table 3). Using tertiles of CAC
instead of CAC as a continuous variable showed similar
results (HR [95% CI]: 1.55 [1.10 to 2.19], p  0.01).
Stratifying by sex, we observed a trend towards a stronger
association of EAT with coronary events in female com-
pared with male subjects (HR [95% CI]: 2.85 [1.76 to 4.63]
vs. 1.55 [1.11 to 2.16]). When further stratifying by the
amount of coronary calcification using a CAC score of 100
as the threshold, we observed higher HRs for subjects with
no or mild calcification compared with subjects with CAC
scores 100 (HR [95% CI]: 2.50 [1.27 to 4.92] and 2.80
[1.44 to 5.45] for CAC 100 vs. 1.11 [0.76 to 1.62] and
1.91 [0.94 to 3.88] for CAC 100 for male and female
subjects, respectively) (Fig. 3). For subjects with CAC  0,
coronary events.ident
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Epicardial Fat and Coronary Events April 2, 2013:1388–95similar HRs as for CAC 100 were observed; however,
analysis was limited by the low number of events in these
subgroups (detailed data not shown).
Of the 91 subjects with nonfatal coronary events, 60
subjects received initial revascularization of a single coronary
artery for acute treatment (the left anterior descending
coronary artery in 24 cases, the left circumflex in 16 cases,
and the right coronary artery in 20 cases). Within this
subgroup, mean pericoronary fat area was 324  158 mm2.
Coronary arteries that developed a culprit lesion during
follow-up causing a coronary event had significantly higher
pericoronary fat area at baseline (378  183 mm2 vs. 297 
38 mm2, respectively, p  0.001).
When investigating the ability of EAT in discriminating
persons with events from those without, we observed a trend
for improvement of Harrell’s C by EAT over traditional
cardiovascular risk factors, but not, however, reaching sta-
tistical significance (increasing from 0.720 to 0.730 when
Figure 2 Event-Free Survival by Quartiles of Epicardial Fat
Kaplan-Meier curves for survival free of coronary events by quartiles of epicardial f
Cox Regression for Fatal or Nonfatalronary Event pe E ch Doubling of Epicardial FatTable 3 Cox Regressi n f r Fatal or Nonf talCoronary Event per Each Doubling of Epicardial Fat
Model
Hazard Ratio
(95% CI) p Value
Unadjusted 2.24 (1.74–2.88) 0.001
Age and sex adjusted 1.63 (1.23–2.17) 0.001
 Traditional cardiovascular risk factors* 1.54 (1.09–2.19) 0.01
 CAC score, log(CAC1) 1.50 (1.07–2.11) 0.02
*Traditional cardiovascular risk factors included waist circumference, systolic blood pressure,
hypertensive medication, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol,i
lipid-lowering medication, diabetes, and smoking.
Abbreviations as in Tables 1 and 2.adding EAT to traditional risk factors, p 0.10). Likewise,
Harrell’s C slightly improved when adding EAT to tradi-
tional cardiovascular risk factors in combination with the
CAC score (0.781 to 0.786 for traditional risk factors and
CAC score, alone and with EAT added, respectively, p 
0.137). To confirm these results, we investigated the expla-
nation of variance for development of coronary events by
risk factors and observed a trend of EAT increasing the
explained variance over traditional risk factors (R2  2.73%
o R2  2.92% for traditional risk factors alone and with
EAT added, IDI(t)  0.196%), indicating that EAT may
improve risk discrimination above traditional cardiovascular
risk factors, while overall effect sizes were low. Consistently,
risk discrimination slightly improved when adding EAT to
cardiovascular risk factors and CAC score (R2  5.09% to
2  5.37% for traditional risk factors and CAC, alone and
ith EAT added, IDI(t)  0.279%).
iscussion
n this study, we examined the association of epicardial fat
olume with traditional cardiovascular risk factors, CAC
cores, and incident fatal and nonfatal coronary events in the
opulation-based Heinz Nixdorf Recall cohort study. We
ound a significant association of EAT volume with cardio-
ascular risk factors in univariable and multivariable analy-
es. By contrast, although CAC scores increased with
uartiles of EAT volume, this effect did not hold when
djusting for traditional cardiovascular risk factors, indicat-at.ng that the association of EAT with CAC is ultimately
1393JACC Vol. 61, No. 13, 2013 Mahabadi et al.
April 2, 2013:1388–95 Epicardial Fat and Coronary Eventsexplained by shared risk factors. EAT volume was signifi-
cantly associated with coronary events, independent of
traditional cardiovascular risk factors. This effect remained
unchanged after further adjustment for the CAC score,
which itself is a strong predictor for coronary events.
Notably, the association of EAT volume with coronary
events was more distinct in subjects with no or mild CAC,
which—together with the lack of association of EAT with
CAC—may support the hypothesis that EAT may be
linked with future coronary events through a mechanistic
pathway different from that of coronary calcification, such as
early and noncalcified plaque burden. Our finding of in-
creased pericoronary fat at the coronary vessel causing a
coronary event during follow-up may suggest that local
visceral adipose tissue supports the development of athero-
sclerosis in the underlying coronary vasculature.
Several studies have demonstrated a strong association
between EAT and coronary plaque burden, as well as with
the presence of coronary heart disease (CHD) (8,12,25). In
part, this is explained by a strong association of EAT with
cardiovascular risk factors (6). However, there is growing
evidence that the correlation of EAT with CHD may not be
fully explained by shared risk factors. A potential explana-
tion is that the endocrine activity of EAT, as with visceral
adipose tissue, secretes pro- and anti-inflammatory media-
tors and cytokines such as adiponectin, interleukin-6, and
tumor necrosis factor alpha (1,3,26,27). Increased CD45
mRNA expression in the EAT of subjects with coronary
artery disease, representing elevated macrophage infiltra-
tion, and an increase of mast cells in the adventitia of
Figure 3 Sex-Specific Association of EAT With Incident Corona
Hazard ratios and 96% confidence intervals (CIs) for the association of epicardial
and amount of coronary artery calcification (CAC) score.coronary lesions have been observed (3,5,26). The hypoth-esis of a mechanism of EAT in the development of CHD
different from that of traditional risk factors is supported by
our findings.
The observed association of EAT with incident coronary
events in our study was independent of coronary calcifica-
tion. This finding is in good agreement with a recent report
by Ito et al. (28), who described an association of epicardial
fat with overall plaque burden even in subjects with zero
CAC. Moreover, Alexopoulos et al. (10) showed that EAT
volume was significantly larger in patients with mixed or
noncalcified plaques compared with patients with calcified
plaques or no plaques, which supports the hypothesis that
EAT may be linked to early plaque components. Likewise,
we and others (8,10,25) have described a significant associ-
ation of epicardial and pericoronary fat with the presence
also of noncalcified plaque burden in the underlying coro-
nary artery. Together with our results, these findings indi-
cate that EAT as quantified from noncontrast cardiac CT
may complement prognostic information drawn from the
CAC score without the need of any extra radiation exposure
or administration of contrast media.
Our finding of a lack of a link between EAT and CAC
scores in a multivariable model is in contrast to the current
literature. Ding et al. (29) described a significant association
of EAT with the presence of coronary calcification inde-
pendent of traditional risk factors in a subgroup of MESA
(the Multi-Ethnic Study of Atherosclerosis). Likewise,
Framingham investigators (6) found EAT to be associated
with the CAC score when adjusting for risk factors and
visceral abdominal fat, whereas no significant link was found
ents and Stratified by Amount of CAC Score
e tissue (EAT) with incident events as stratified by sexry Ev
adiposwhen adjusting for traditional risk factors only.
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Epicardial Fat and Coronary Events April 2, 2013:1388–95Although several studies demonstrated an association of
EAT with prevalent CHD, data on incident CHD are
limited (12,30). In a recent case-control study based on the
Multi-Ethnic Study of Atherosclerosis cohort, an increase
of CHD probability by quartile of EAT volume as well as a
significant association of epicardial fat with incident CHD
was described that remained statistically significant after
adjustment for body mass index and cardiovascular risk
factors (14). Similar results were observed in a case-control
analysis drawn from a registry of asymptomatic subjects
undergoing cardiac CT, where EAT was associated with
incident cardiac events (31). These findings are confirmed
by our results in a large population-based cohort with EAT,
providing prognostic information and improving risk pre-
diction for first coronary events.
Implications. Our results indicate that increased amounts
of EAT volume are associated with excessive risk for fatal or
nonfatal coronary events, independent of traditional cardio-
vascular risk factors. The finding of a strong correlation of
EAT with coronary events independent of CAC and the
lack of association of EAT with CAC suggest that EAT
may be linked with future coronary events through a
mechanistic pathway different from that of coronary calci-
fication, such as early and noncalcified plaque burden.
Therefore, EAT volume may complement prognostic infor-
mation drawn from calcium scoring and increase the pre-
dictive value of noncontrast cardiac CT, which can be
quantified without additional radiation exposure or contrast
administration.
Overall, subjects with high EAT may qualify for inten-
sified risk factor modification. Because physical activity and
weight changes have a major impact on visceral adiposity in
general and EAT in specific (32,33), lifestyle changes may
be of particular importance in preventing myocardial infarc-
tion in subjects with increased EAT volume.
Study strengths and limitations. Strengths of our study
include the population-based design without selection of
the cohort to adiposity-related traits. Traditional cardiovas-
cular risk factors were measured using highly standardized
protocols, and EAT was quantified using a reproducible,
volume-based method. However, different definitions of
pericardial and epicardial fat volume are established in the
literature, and other measures of thoracic adipose tissues,
such as intrathoracal fat or pericoronary fat quantification as
described in the literature (7,8), were not tested in compar-
ison. Because our study was conducted in a predominantly
Caucasian population, generalization to other ethnic groups
remains uncertain.
Conclusions
Epicardial fat is independently associated with fatal or
nonfatal coronary events in the general population indepen-
dent of traditional cardiovascular risk factors and the CAC
score. Our results suggest that EAT complements informa-tion derived from the CAC score and therefore may increase
the value of noncontrast cardiac CT examinations.
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